mannosebind
lectin
mbl
ctype
collectin
structur
similar
innat
patternrecognit
molecul
sequest
site
inflamm
infect
mbl
select
bind
distinct
chemic
pattern
includ
carbohydr
express
kind
pathogen
present
studi
show
serum
mbl
level
influenc
abil
chicken
clear
respiratori
tract
viru
genom
infecti
bronchiti
viru
ibv
infect
primari
ibv
infect
induc
chang
circul
tcell
popul
specif
antibodi
respons
serum
mbl
level
also
influenc
ibv
vaccineinduc
chang
circul
tcell
popul
moreov
addit
mannos
ibv
vaccin
alter
vaccineinduc
chang
circul
tcell
popul
ibv
specif
vaccin
infectioninduc
antibodi
respons
chicken
high
serum
mbl
level
data
demonstr
mbl
involv
regul
adapt
immun
respons
ibv
innat
immun
system
consid
first
line
defens
infect
innat
immun
system
react
promptli
invad
pathogen
instruct
antigen
present
cell
apc
activ
secret
cytokin
among
thing
regul
tand
b
cell
toward
appropri
adapt
effector
phenotyp
activ
apc
respons
pathogen
stimuli
mediat
uniqu
patternrecognit
receptor
prr
result
product
proinflammatori
cytokin
costimulatori
molecul
particip
activ
adapt
immun
respons
sever
solubl
prr
character
lpsbind
protein
collectin
pentraxin
altern
pathway
complement
compon
addit
cellassoci
receptor
like
ctype
lectin
scaveng
receptor
tolllik
receptor
tlr
variou
intracellular
receptor
mani
prr
highli
conserv
provid
cornerston
upon
antimicrobi
immun
respons
built
moreov
vaccineinduc
protect
immun
regul
prr
stimul
pathogenassoci
molecular
pattern
pamp
order
perform
adjuv
effect
central
success
vaccin
serum
protein
mannosebind
lectin
mbl
import
solubl
prr
belong
ctype
collectin
famili
mbl
bind
mannos
sugar
residu
present
cell
wall
bacteria
virus
parasit
high
affin
sugar
natur
occur
higher
organ
mbl
repres
import
mechan
discrimin
pathogen
host
mbl
exhibit
number
innat
immunolog
properti
bind
eg
microbi
cell
wall
antigen
mbl
act
opsonin
mediat
phagocytosi
directli
mbl
receptor
express
surfac
neutrophil
monocyt
altern
mbl
activ
complement
system
lectin
pathway
caus
pathogen
lysi
phagocytosi
via
complement
receptor
phagocyt
cell
addit
mbl
import
remov
circul
immun
complex
knowledg
function
role
mbl
immun
human
anim
increas
individu
mbl
defici
report
suscept
viral
bacteri
infect
well
see
front
matter
elsevi
ltd
right
reserv
autoimmun
diseas
especi
earli
neonat
period
render
neutropen
chemotherapi
also
shown
mbl
defici
human
genet
basi
result
lab
use
chicken
select
high
low
serum
concentr
mbl
shown
low
amount
circul
mbl
associ
increas
viral
replic
airway
infecti
bronchiti
viru
ibv
infect
reduc
growth
rate
e
coli
infect
also
shown
low
mbl
concentr
associ
increas
number
pasteurella
multocida
spleen
nonselect
exot
breed
infect
final
preliminari
result
parasit
ascaridia
galli
show
parasit
egg
burden
post
infect
higher
bird
low
serum
mbl
concentr
unpublish
result
confirm
mbl
proven
mammal
play
major
role
outcom
variou
infect
chicken
invers
relationship
pathogenspecif
antibodi
respons
serum
mbl
level
record
inbr
well
outbr
chicken
recent
also
shown
mous
model
specif
igg
respons
increas
mbldefici
mice
follow
immun
group
b
streptococcu
vaccin
doubl
mbl
knockout
mice
inject
solubl
hepat
b
surfac
antigen
result
suggest
mbl
influenc
product
specif
antibodi
either
direct
immun
respons
cellular
respons
vs
neutral
microorgan
via
complement
membraneattack
complex
andor
inhibit
product
proinflammatori
cytokin
via
interact
surfac
receptor
latter
shown
human
wholeblood
model
low
concentr
mbl
enhanc
cytokin
product
high
concentr
suppress
cytokin
product
detail
understand
interact
innat
adapt
immun
lead
new
approach
improv
vaccin
effici
eg
blockinginhibit
mbl
function
may
lead
discoveri
new
adjuv
vaccin
industri
futur
import
issu
breed
compani
current
focu
select
marker
belong
innat
part
immun
system
effort
produc
robust
anim
improv
genet
determin
diseas
resist
attract
inexpens
approach
improv
health
statu
product
anim
therefor
challeng
futur
vaccin
strategi
choos
optim
adjuv
design
innat
robust
anim
thu
vaccin
may
necessari
temporarili
overcom
contribut
innat
part
immun
system
order
allow
develop
adapt
immun
respons
infecti
bronchiti
ib
highli
contagi
viral
respiratori
diseas
domest
fowl
occur
worldwid
caus
great
loss
poultri
industri
due
neg
impact
product
result
vaccin
cost
infect
extrem
difficult
control
vaccin
one
strain
ibv
necessarili
protect
diseas
caus
strain
ibv
hypothesi
studi
therefor
temporari
blockinginhibit
mbl
function
ad
mbl
ligand
vaccin
would
allow
adapt
immun
respons
produc
specif
antibodi
better
develop
protect
immun
order
address
perform
experi
chicken
vaccin
ib
without
mannos
ad
vaccin
follow
challeng
ibv
immunolog
paramet
belong
innat
well
adapt
immun
system
measur
throughout
experiment
period
experiment
chicken
n
offspr
au
line
select
low
l
vs
high
h
concentr
mbl
serum
sever
gener
offspr
rear
togeth
week
age
convent
condit
biosecur
ibvfre
herd
alloc
differ
treatment
group
bird
sublin
group
first
group
treat
l
nacl
solut
use
mockvaccin
control
group
second
group
treat
l
nacl
solut
contain
one
dose
live
attenu
nobili
ib
vet
intervetscheringplough
anim
health
ballerup
denmark
third
group
treat
l
nacl
solut
contain
one
dose
nobili
ib
vet
mgml
purifi
mannan
saccharomyc
cerevisia
sigmaaldrich
denmark
aim
g
mannos
per
gram
bodi
weight
solut
given
half
nasal
half
oral
day
age
bird
transfer
facil
randomli
alloc
isol
contain
anim
day
age
bird
infect
l
steril
allantoid
solut
ibv
strain
veterinari
laboratori
agenc
weybridg
uk
contain
eld
ibv
chicken
fed
diet
met
exceed
nrc
requir
feed
water
provid
ad
libitum
experiment
chicken
blood
sampl
jugular
vein
day
post
vaccin
pv
day
post
infect
pi
serum
collect
blood
sampl
time
point
citratestabil
blood
immun
phenotyp
collect
day
pv
day
pi
oropharyng
airway
opa
swab
sampl
collect
day
pv
day
pi
swab
sampl
kept
c
termin
experi
transfer
c
kept
test
rtpcr
four
swab
sampl
subtyp
treatment
day
pool
thu
pool
per
group
analyz
time
point
tube
swab
shaken
vigor
h
thaw
supernat
collect
min
centrifug
g
purif
rna
done
accord
instruct
rneasi
kit
qiagen
copenhagen
denmark
rtpcr
carri
accord
manufactur
instruct
titantm
one
tube
rtpcr
system
boehring
mannheim
util
avian
myeloblastosi
viru
revers
transcriptas
blend
pwo
taq
dna
polymeras
briefli
reaction
l
reaction
buffer
l
mm
dithiothreitol
l
dntp
mm
dntp
l
enzym
mixtur
pmol
oligonucleotid
l
rna
rnasefre
water
l
stock
mixtur
kept
ice
transfer
thermocycl
abacu
hybaid
rtpcr
carri
use
follow
program
cycl
min
c
rt
reaction
cycl
c
cycl
c
c
c
cycl
c
min
rtpcr
reaction
perform
ibvn
ibvn
primer
identifi
massachusettsconnecticut
strain
presenc
pcr
product
l
sampl
l
control
sampl
confirm
agaros
gelelectrophoresi
use
seakem
gtg
fmc
agaros
mgml
ethidium
bromid
band
subject
densiometr
analys
raw
volum
band
record
use
genegeniu
gel
document
system
syngen
cambridg
uk
raw
volum
defin
threedimension
size
band
intens
third
dimens
data
analyz
use
genetool
softwar
syngen
cambridg
uk
posit
control
pcr
fragment
origin
purifi
ibv
strain
set
experiment
sampl
estim
percentag
elisa
measur
concentr
total
mbl
serum
perform
previous
describ
briefli
microtit
plate
nunc
roskild
denmark
coat
gml
monoclon
antichicken
mbl
antibodi
state
serum
institut
copenhagen
denmark
nonspecif
bind
block
l
serum
dilut
ad
well
incub
bound
mbl
detect
gml
biotinyl
horseradish
peroxidas
hrp
conjug
streptavidin
dako
glostrup
denmark
use
visual
mbl
concentr
serum
sampl
calcul
linear
regress
standard
curv
known
concentr
mbl
proflok
ibv
elisa
test
kit
synbiot
san
diego
ca
use
measur
igg
specif
antibodi
titer
ibv
serum
elisa
perform
accord
kit
manual
briefli
microtit
plate
coat
ibv
antigen
incub
l
dilut
serum
sampl
posit
neg
control
includ
kit
follow
incub
horseradish
peroxidas
conjug
affin
purifi
antibodi
pool
serum
goat
immun
chicken
igg
hl
azinodi
benzthiazolin
sulfon
acid
abt
use
chromogen
sodium
dodecyl
sulfat
sd
stop
solut
result
monitor
optic
densiti
od
nm
antibodi
titer
calcul
follow
equat
format
sp
sampl
absorb
averag
normal
control
absorb
correct
posit
control
absorb
accord
kit
manual
distribut
differ
tcell
subset
measur
whole
blood
protocol
immunophenotyp
stain
fifti
microlit
citratestabil
blood
mix
l
antibodi
solut
contain
l
facsbuff
bsa
sodium
azid
normal
hors
serum
pb
cell
suspens
incub
c
min
tube
dark
wash
ml
facsbuff
centrifug
g
min
supernat
discard
cell
resuspend
l
facsbuff
flow
cytometr
analys
perform
bd
facscanto
beckton
dickinson
equip
nm
blue
laser
nm
red
laser
minimum
cell
storag
gate
fscsscdefin
lymphocyt
gate
collect
sampl
use
facsdiva
softwar
singlestain
compens
control
well
neg
fluoresc
minu
one
fmo
control
includ
monoclon
antibodi
obtain
southern
biotech
birmingham
al
licens
conduct
anim
experi
obtain
danish
ministri
justic
anim
experiment
inspector
hell
r
juulmadsen
experi
conduct
accord
ethic
guidelin
model
use
follow
g
j
g
ij
e
overal
mean
g
fix
effect
ith
genet
group
fix
effect
jth
sampl
day
e
residualnot
explain
analysi
varianc
perform
glm
procedur
sa
softwar
chicken
select
high
h
low
l
mbl
serum
vaccin
day
age
commerci
attenu
live
ibv
vaccin
follow
challeng
infect
massachusett
strain
ibv
chicken
divid
three
group
mockvaccin
group
vaccin
ibv
vaccin
without
mannos
ad
group
vaccin
ibv
vaccin
contain
mannos
group
chicken
challeng
ibv
day
pv
replic
vaccin
viru
pv
viru
pi
opa
monitor
massachusettsconnecticut
strain
specif
rtpcr
swab
sampl
day
pv
day
pi
group
test
infect
fig
pcramplifi
product
subject
densitometri
analysi
adjust
posit
control
contain
purifi
set
adjust
percentag
viru
genom
shown
fig
vaccin
viru
detect
opa
day
peak
day
pv
differ
observ
two
group
group
pv
infect
viral
genom
detect
vaccin
chicken
group
unvaccin
chicken
group
hand
high
replic
viral
genom
day
pi
day
pi
appear
number
viral
genom
decreas
hchicken
still
lchicken
day
pi
unvaccin
chicken
clear
viru
opa
mbl
acut
phase
respons
serum
sampl
measur
whole
experiment
period
fig
respons
seen
pv
mock
vaccin
group
neither
hchicken
lchicken
howev
group
weak
acut
phase
respons
observ
vaccinationmost
pronounc
lchicken
respons
peak
day
pv
follow
decreas
mbl
serum
level
day
pv
day
mbl
level
baselin
seen
day
pv
approx
decreas
mbl
level
subsequ
increas
higher
level
baselin
infect
approx
increas
pronounc
hchicken
increas
agedepend
sinc
mockvaccin
group
h
l
ident
mbl
level
day
pv
day
pi
expect
mockvaccin
group
group
higher
mbl
acut
phase
respons
infect
two
vaccin
group
group
upon
challeng
infect
lchicken
peak
day
pi
wherea
hchicken
peak
twice
day
respect
subsequ
sublin
group
show
decreas
amount
mbl
day
pi
approx
increas
observ
sublin
group
end
experi
higher
level
serum
mbl
infect
infect
approx
compar
observ
group
pv
ibv
specif
igg
antibodi
titer
measur
elisa
week
experi
fig
expect
chicken
group
neg
ibv
antibodi
challeng
infect
seroconvers
detect
day
pi
termin
day
experi
differ
two
sublin
observ
ibv
titer
lchicken
appear
highest
titer
although
significantli
group
lchicken
tend
higher
antibodi
titer
day
pv
p
challeng
infect
high
product
antibodi
observ
alreadi
day
pi
sublin
titer
decreas
howev
differ
antibodi
titer
sublin
observ
pi
due
larg
variat
bird
group
hand
lchicken
show
clear
antibodi
respons
pv
higher
mean
antibodi
titer
day
pv
p
day
pv
p
compar
hchicken
challeng
infect
differ
land
hchicken
even
pronounc
lchicken
display
significantli
higher
antibodi
titer
hchicken
day
pi
p
p
flow
cytometr
protocol
use
stain
tcell
subset
whole
blood
tcell
subset
identifi
via
fscssc
gate
small
lymphocyt
identif
hi
posit
cell
lymphocyt
follow
identif
posit
cell
final
subdivid
posit
cell
singl
posit
cell
singl
posit
cell
doubl
posit
cell
fig
result
present
fig
group
differ
percentag
cell
found
infect
percentag
cell
lchicken
higher
hchicken
day
pi
p
similar
tendenc
seen
day
pi
p
group
percentag
cell
lchicken
higher
hchicken
day
pv
p
day
pi
p
group
percentag
cell
lchicken
higher
hchicken
day
pi
p
differ
percentag
cell
includ
doubl
posit
cell
found
sublin
treatment
singl
posit
cell
doubl
posit
cell
combin
due
individu
differ
percentag
doubl
posit
cell
origin
posit
cell
data
shown
final
major
differ
sublin
found
cell
posit
neg
group
percentag
cell
hchicken
higher
lchicken
day
pi
p
similar
tendenc
seen
day
pi
p
group
percentag
cell
hchicken
higher
lchicken
day
pv
p
final
percentag
cell
hchicken
higher
lchicken
day
pv
day
pi
group
follow
primari
ibv
infect
group
high
level
viru
replic
observ
oropharyng
airway
bird
howev
day
pi
viru
clear
respiratori
tract
hchicken
wherea
clearanc
occur
lchicken
day
pi
fig
indic
anim
low
mbl
concentr
serum
harbor
viru
longer
anim
high
mbl
concentr
previous
suggest
addit
mannos
vaccin
alter
capac
induc
protect
immun
sinc
replic
viru
found
sampl
vaccin
group
infect
ibv
strain
even
though
use
high
dose
viru
challeng
recent
new
field
strain
ibv
isol
domest
poultri
china
qx
europ
qxlike
ibv
caus
sever
loss
layer
broiler
industri
vaccin
longer
fulli
protect
new
strain
hindsight
one
strain
may
better
choic
challeng
viru
sinc
group
anim
protect
infect
strain
order
detect
effect
mbl
mannos
relat
vaccineinduc
protect
ibv
virul
strain
therefor
use
experi
analog
previou
result
mbl
acut
phase
respons
observ
ibv
vaccin
infect
follow
decreas
baselin
level
fig
present
studi
respons
pronounc
group
challengeinfect
acut
phase
respons
much
weaker
challeng
infect
two
vaccin
group
group
probabl
due
adapt
memori
respons
influenc
mannos
addit
vaccin
observ
serum
mbl
level
decreas
serum
mbl
vaccin
infect
baselin
level
may
due
feedback
mechan
part
immun
system
feedback
mechan
may
occur
mbl
transcript
level
altern
transfer
mbl
blood
infect
tissu
therebi
lower
concentr
mbl
blood
propos
valdimarsson
et
al
simpli
mbl
use
opson
thu
engulf
phagocyt
cell
decreas
follow
increas
baselin
level
three
group
explan
age
left
explan
least
vaccin
sinc
increas
mockvaccin
group
previous
shown
inbr
well
outbr
anim
neg
correl
concentr
mbl
serum
abil
produc
specif
antibodi
infect
may
caus
interplay
innat
adapt
immun
system
studi
found
differ
specif
antibodi
titer
hand
lchicken
group
infect
differ
may
attribut
time
point
chosen
termin
experi
ie
earli
titer
viru
calcul
eld
ie
high
hand
find
differ
two
sublin
group
receiv
mannos
togeth
vaccin
pv
pi
fig
hchicken
receiv
mannos
combin
vaccin
show
low
specif
ibv
igg
antibodi
titer
compar
lchicken
treatment
group
wherea
titer
land
hchicken
similar
group
receiv
mannos
indic
high
serum
level
mbl
influenc
product
specif
antibodi
addit
mannos
high
bird
mbl
high
mbllevel
alter
antibodi
product
neg
way
likewis
one
may
likewis
specul
bird
constant
low
level
serum
mbl
compensatori
mechan
induct
regul
antibodi
respons
activ
therefor
mannos
addit
affect
antibodi
product
lchicken
direct
involv
mannos
specif
receptor
rule
sinc
differ
found
lchicken
group
presum
receptor
genet
ident
two
sublin
mention
earlier
higher
specif
igg
respons
found
mbldefici
mice
follow
immun
group
b
streptococcu
vaccin
suggest
mbl
play
inhibit
role
igg
antibodi
product
shown
increas
antibodi
restrict
tcelldepend
antigen
antibodi
subtyp
high
affin
fc
receptor
phagocytot
cell
indic
mbl
play
role
regul
adapt
immun
respons
signal
antigen
present
cell
recent
support
paper
zhou
et
al
show
direct
mblmediat
neutral
sever
acut
respiratori
syndromecoronaviru
sarscov
block
bind
viru
specif
glycoprotein
sarss
dcsign
receptor
dendrit
cellspecif
intercellular
adhes
molecul
nonintegrinrel
molecul
suggest
mbl
like
recogn
overlap
set
highmannosecont
glycan
glycoprotein
therebi
compet
dcsign
bind
dcsign
known
bind
differ
pathogen
trigger
intracellular
signal
cascad
affect
tlr
signal
therebi
adapt
immun
respons
review
specif
modul
immun
respons
depend
pathogen
involv
lead
inhibit
promot
helper
type
polar
respons
andor
induct
regulatori
cell
differenti
chicken
shown
protein
ibv
alon
suffici
induc
protect
better
understand
humor
respons
necessari
measur
titer
ibvspecif
igm
antibodi
shown
mbl
intim
involv
prime
humor
ab
respons
mice
carter
et
al
found
profound
abrog
antigenspecif
igm
level
b
malayiinfect
mbla
defici
mice
addit
higher
level
igg
isotyp
thu
suggest
mbla
play
critic
role
level
igm
product
andor
regul
degre
class
switch
igg
isotyp
howev
mention
even
though
hchicken
low
specif
antibodi
titer
studi
chicken
protect
infect
viru
replic
opa
fig
indic
antibodi
may
decis
protect
ibv
previous
suggest
other
order
address
cellular
immun
respons
phenotyp
three
differ
gener
circul
tcell
popul
high
dim
perform
present
experi
fig
within
popul
major
high
cell
circul
tcell
receptor
tcr
tcell
express
heterodim
surfac
fig
ie
cytotox
tlymphocyt
ctl
phenotyp
cell
consid
classic
thelper
cell
wherea
major
dim
posit
cell
also
carri
molecul
cell
surfac
henc
doubl
posit
tcr
tcell
express
homodim
function
latter
popul
still
unknown
chicken
pig
identifi
memori
cell
circul
chicken
domin
tcr
express
tcell
chicken
belong
group
anim
tcell
circul
suggest
tcell
play
import
role
chicken
immun
system
howev
function
chicken
tcell
still
larg
unknown
vitro
studi
shown
cytotox
immunoregulatori
properti
moreov
known
chicken
tcell
recogn
classic
peptid
mhc
antigen
bind
altern
antigen
mammal
function
tcell
likewis
firmli
identifi
studi
human
cattl
instanc
reveal
exist
sever
subpopul
tcell
recogn
mhc
nonmhcassoci
antigen
studi
suggest
number
function
killer
cell
classic
cell
central
memori
immunemodul
cytokin
product
antigen
present
cell
overal
dim
cell
influenc
vaccin
infect
present
studi
howev
hchicken
decreas
high
cell
case
complement
increas
cell
observ
ibv
vaccin
infect
fig
increas
cell
pronounc
hchicken
mannos
ad
vaccin
group
interestingli
recent
shown
human
tcell
prolifer
express
memori
marker
produc
cytokin
respons
infect
candida
albican
contain
mannos
structur
result
fig
indic
role
tcell
defens
ibv
especi
chicken
low
level
specif
antibodi
viru
eg
killer
cell
altern
explan
high
tcell
ie
ctl
chicken
transloc
circul
respiratori
organ
shown
adopt
transfer
tcell
bear
molecul
critic
protect
chicken
ibv
infect
could
howev
address
absolut
rather
rel
count
differ
tcell
subtyp
blood
obviou
next
experi
conclus
mbl
seem
associ
clearanc
ibv
previous
indic
acut
mbl
respons
peak
day
pv
pi
follow
regul
pronounc
hchicken
specif
antibodi
titer
highest
lchicken
mannos
seem
inhibit
product
specif
antibodi
hchicken
hchicken
hand
show
decreas
cell
increas
tcell
vaccin
infect
suggest
antibodi
tcell
complementari
function
protect
ibv
result
indic
mbl
involv
regul
adapt
immun
respons
ibv
mbl
therefor
consid
design
futur
vaccin
relat
inhibit
promot
thelper
type
polar
respons
andor
induct
tcell
research
need
elucid
import
mbl
includ
studi
mbl
ligand
